Sort By
  • Newest

  • Newest

  • Oldest

  • Author Name

  • Author Name

  • David Chaplin

  • Drew Meredith

  • Giselle Roux

  • Greg Bright

  • Ishan Dan

  • James Dunn

  • Lachlan Maddock

  • Owen Raszkiewicz

IPO Watch: Battery listings soar, biotechs take a backseat

While the crisis in Ukraine enters its fourth month, the knock-on effect caused by supply disruptions to energy and commodity prices has been a positive windfall for companies listing in April. In total there were 13 companies that listed on the ASX, with the majority being either energy- or materials-focused, in particular, battery minerals (lithium)…

Ishan Dan | 22nd Apr 2022 | More
A bullish view on two blue chips

I believe there are a few ASX blue-chip shares that have better futures than the market is giving credit. Every business on the ASX (and other global stock exchanges) has a share price. That share price has expectations built into it – the future profit margins, how much revenue could grow, market share, potential dividends,…

Contributor | 22nd Apr 2022 | More
  • Market is ‘too negative’ on China: Platinum

    Value managers are seeing somewhat of a renaissance in 2022; at the very least, those which have been overweight underperforming materials, financials and traditional cyclical companies have done exceptionally well. Platinum Asset Management (ASX:PTM) remains one of Australia’s most well-known value managers, but the last decade has not been easy for the firm. In fact,…

    Drew Meredith | 13th Apr 2022 | More
    Why this cohort is dominating ETF flows

    As it stands in 2022, 1.7 million Australians are now invested into exchange-traded funds (ETFs); that represents 33 per cent growth on a year ago. For the uninitiated, an ETF is simply an investment product, structured as a unit trust, which holds shares on behalf of the investor and is listed on a stock exchange…

    Drew Meredith | 8th Apr 2022 | More
  • Unique options to protect the downside in portfolios

    During times of crisis such as the current war in Ukraine and rising global tensions, markets tend to fall because of fear and uncertainty. Advisers looking for a way to hedge against this declining market or the possibility of a decline to come might want to consider using covered call options for their clients, especially…

    Ishan Dan | 8th Apr 2022 | More
    Measuring profit in a world of one-offs

    The Sage of Omaha, Warren Buffett, recently highlighted a growing issue within financial markets in his annual letter to shareholders, the idea of earnings versus profit. He drew attention to the fact that Berkshire Hathaway relies on ‘old-fashioned’ profits, not modern measures of ‘earnings’ that can be easily manipulated by boards and accountants. Earnings, profits…

    Drew Meredith | 6th Apr 2022 | More
    What’s the difference between an on and off market buy back?

    Buybacks have been all the rage in last the few years. Triggered by the availability and low cost of capital, US listed companies in particular have embraced the strategy with great gusto. The idea is quite simple; if you have excess cash in your company, why not buy back your own shares, in effect “investing…

    Drew Meredith | 1st Apr 2022 | More
    The ten most powerful investment themes of 2022

    Against a backdrop of deepening geopolitical tensions, heightened inflation and rising interest rates, First Sentier are hoping for smoother sailing this year. But with inflation on the rise the outlook is far from clear. The asset manager’s portfolio managers have listed 10 investment themes that will be on their watchlist for the remainder of the…

    Ishan Dan | 30th Mar 2022 | More
    Understanding listed investment trusts

    Listed Investment Trust (LITs) have become the latest income-producing craze, with income-seeking investors starting to consider a switch to the closed-ended trusts. What are LITs and LICs? Firstly, listed investment companies (LICs) and listed investment trusts (LITs) are both managed investments that are listed on the ASX, and have a range of unique characteristics. LICs…

    Ishan Dan | 25th Mar 2022 | More
  • One little prick that could go a long way

    Blood diagnostic company Haemokinesis Limited is ASX-bound, with its $17 million share issue, at 20 cents a share, closing this Wednesday, with Haemokinesis expected to commence trading on the exchange on Friday, 8 April. When it hits the screens Haemokinesis will have a market capitalisation of $77 million. Haemokinesis – which means “moving blood with…

    James Dunn | 18th Mar 2022 | More
    Ukraine war to cut growth, boost inflation

    The deepening war crisis in Ukraine is showing no sign of abating any time soon, with inflation hitting historical highs as war effects compound inflation triggered by the Covid-19 pandemic. BlackRock has released a research note covering its macro and geo-political view. The global asset manager says, “The war in Ukraine has already caused a…

    Ishan Dan | 18th Mar 2022 | More
    Strong investment set to drive ASX earnings: Ausbil

    And that’s a wrap. Another positive earnings season, with 47 per cent of the S&P/ASX 200 Index beating on revenue estimates and 44 per cent beating on EPS (earnings per share) estimates. Ausbil Investment Management has released its reporting season wrap and outlook for earnings going forward. Here are the highlights: HY22 was another positive…

    Ishan Dan | 18th Mar 2022 | More
    1 7 8 9 10 11 13